IP Library Granted Patent US 12,533,302
Granted Patent B2
US 12,533,302 · App. 17/683,813 · Granted Jan 27, 2026

Systems and methods for delivery of actives and healing tissue

Inventors: Amy Billups Batra (New Hope, PA); Jaya Krishna Rose Batra (New Hope, PA); Sanjay Batra (New Hope, PA)
A61K8/0212A61K8/042A61Q19/00A61Q19/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,533,302
App. No.
17/683,813
Granted
Jan 27, 2026
Kind
B2
Abstract

Described herein are delivery systems comprising a deformable substrate comprising a hydrophobic surface; an active ingredient; wherein all of the active ingredient is on said hydrophobic surface; a hydrogel and water; along with methods of using and making same. The delivery systems are designed to deliver active ingredients to and through the skin surface.

Claims (23)

1 . A facial mask comprising:

an active ingredient; and

a deformable substrate having a proximal side and a distal side, comprising:

a hydrogel comprising:

a polymeric component; and

water;

wherein the hydrogel has a hydrophobic surface;

wherein all of the active ingredient is present on said hydrophobic surface;

wherein the active ingredient is selected from: platelet-rich plasma; growth factors; an exosome, stem cells; a secretome; and a combination of two or more thereof; and

wherein the polymeric component and water are present in a ratio of from about 1:5 to about 1:1.

2 . The facial mask according to claim 1 , wherein the polymeric component comprises a polymer selected from: an acrylate polymer; a cellulosic polymer; poly alkyl vinyl ether-maleic acid copolymer; polyvinyl alcohol; polyacrylic acid; a poloxamer; polyvinyl pyrrolidone-vinyl acetate copolymer; polyvinyl pyrrolidone; polyquaternium-11; polyquaternium-39; a carbomer; gelatin; an alginate salt; and a combination of two or more thereof.

3 . The facial mask according to claim 1 , wherein the proximal side of the deformable substrate is hydrophobic.

4 . The facial mask according to claim 1 , further comprising a backing layer and/or a protective layer.

5 . The facial mask according to claim 1 , wherein the deformable substrate is a multi-piece substrate.

6 . The facial mask according to claim 1 , further comprising a scrim comprising a non-woven fiber; and wherein the scrim comprises a fibrillary network having a fiber density effective to provide sufficient rigidity to the facial mask.

7 . A method of treating a skin surface, comprising:

applying a delivery system according to claim 1 , to a skin surface of a mammal in need thereof.

8 . The method according to claim 7 , wherein the deformable substrate is configured to retain up to about 10 ml of liquid on the hydrophobic surface.

9 . The method according to claim 7 , wherein the delivery system is applied after a dermatological procedure selected from: a facial; a chemical peel; microdermabrasion; ablative laser resurfacing; non-ablative resurfacing; micro-needling; ultrasound; cryotherapy; radiofrequency; and a combination of two or more thereof.

10 . The method according to claim 9 , wherein the dermatological procedure is an injectable procedure comprising administration of a dermal filler selected from: collagen; calcium hydroxyapatite (CaHA); hyaluronic acid (HA); autologous fat; poly-L-lactic acid; polymethylmethacrylate (PMMA); and a combination of two or more thereof; a neuromodulator selected from: onabotulinumtoxin A; incobotulinumtoxin A; and abobotulinumtoxin A, or regenerative cells selected from: platelet-rich plasma; growth factors; an exosome, stem cells; a stem cell serum; a secretome; a stomal vascular fraction; an anti-aging topical composition; a mineral; a vitamin; and a combination of two or more thereof.

11 . The method according to claim 7 , wherein the backing layer is removed after application of the delivery system to the skin surface; and wherein removal of the backing layer provides a cooling effect to the skin surface.

12 . The method according to claim 7 , wherein the delivery system is substantially free of tenting after it is applied to the skin surface of the mammal.

13 . The facial mask according to claim 1 , wherein the facial mask is held in place without an adhesive.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2025
From: WETHRIVV LLC
To: VIAS PARTNERS, LLC
Reel/Frame 071311/0226 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: VIAS PARTNERS, LLC
To: WETHRIVV LLC
Reel/Frame 062180/0877 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 1, 2022
From: BATRA, AMY BILLUPS; BATRA, JAYA KRISHNA ROSE; BATRA, SANJAY
To: VIAS PARTNERS, LLC
Reel/Frame 059135/0322 →
Continuity (2)
Provisional Application 63155234 · Mar 1, 2021
Related Publication 20220304902A1 · Sep 29, 2022
References Cited (23)
US 2973282A · Gross · 1961 [cited by applicant]
US 3307544A · Gander et al. · 1967 [cited by applicant]
US 7470656B2 · Sherry et al. · 2008 [cited by examiner]
US 8372130B2 · Young · 2013 [cited by applicant]
US 8927605B2 · Subkowski et al. · 2015 [cited by applicant]
US 10448727B2 · Ito et al. · 2019 [cited by applicant]
US 20030167556A1 · Kelley · 2003 [cited by applicant]
US 20050074482A1 · Goldman · 2005 [cited by examiner]
US 20060015083A1 · Munro et al. · 2006 [cited by examiner]
US 20070087061A1 · Drake et al. · 2007 [cited by examiner]
US 20110208101A1 · Keller · 2011 [cited by examiner]
US 20130084305A1 · Iwama · 2013 [cited by examiner]
US 20140235727A1 · Tufts · 2014 [cited by examiner]
US 20200170381A1 · Park · 2020 [cited by examiner]
CN 108853713A · 2018 [cited by applicant]
Fathi-Azarbayjani (AAPS PharmSciTech, vol. 11, No. 3, Sep. 2010, p. 1164-1170) Novel Vitamin and Gold-Loaded Nanofiber Facial Mask for Topical Delivery (Year: 2010). [cited by examiner]
Hettiaratchi et al. (APL Bioengineering 2, 026110 (2018) A rapid method for determining protein diffusion through hydrogels for regenerative medicine applications (Year: 2018). [cited by examiner]
Axpe et al. (Macromolecules pubs.acs.org/Macromolecules 2019, 52, 6889-689) A Multiscale Model for Solute Diffusion in Hydrogels (Year: 2019). [cited by examiner]
Potts and Francoeur, “The Influence of Stratum Corneum Morphology on Water Permeability” Journal of Investigative Dermatology vol. 96, Issue 4, Apr. 1991, pp. 495-499 (Year: 1991). [cited by examiner]
Thomas et al. (“Hydrophilic-hydrophobic hydrogels for cartilage replacement” Journal of the Mechanical Behavior of Biomedical Materials vol. 2, Issue 6, Dec. 2009, pp. 588-595) (Year: 2009). [cited by examiner]
A. Batra (https://maskad.co/products/hydrogel-infusion-face-mask?srsltid=AfmBOoqfLuqahGN-W1EDMt4aQMMLJJqmWsBfs73KVsfTIEpjBjXY2C0s; pub. Jan. 26, 2024, see bottom video), (Year: 2024). [cited by examiner]
Pan et al. “Multifunctional Superhydrophobic Surfaces Templated From Innately Microstructured Hydrogel Matrix” (ACS Nano Lett., 14, 4803-4809, pub. Jun. 30, 2014) (Year: 2014). [cited by examiner]
Larrañeta et al. “Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications” (J. Funct. Biomater., 9, 13, pub. Jan. 24, 2018) (Year: 2018). [cited by examiner]